@article{41be857b7f5e4a419f07a9b68b9214f2,
title = "Natural COA water inhibits mitochondrial ROS-mediated apoptosis through Plk3 downregulation under STZ diabetic stress in pancreatic β-cell lines",
abstract = "Diabetes from pancreatic β cell death and insulin resistance is a serious metabolic disease in the world. Although the overproduction of mitochondrial reactive oxygen species (ROS) plays an important role in the pathogenesis of diabetes, its specific molecular mechanism remains unclear. Here, we show that the natural Charisma of Aqua (COA) water plays a role in Streptozotocin (STZ) diabetic stress-induced cell death inhibition. STZ induces mitochondrial ROS by increasing Polo-like kinase 3 (Plk3), a major mitotic regulator, in both Beta TC-6 and Beta TC-tet mouse islet cells and leads to apoptosis. Overexpression of Plk3 regulates an increase in mitochondrial ROS as well as cell death, also these events were inhibited by Plk3 gene knockdown in STZ diabetic stimulated-Beta TC-6 cells. Interestingly, we found that natural COA water blocks mitochondrial ROS generation through the reduction of Plk3 and prevents apoptosis in STZ-treated beta cells. Furthermore, using the 3D organoid (ex vivo) system, we confirmed that the insulin secretion of the supernatant medium under STZ treated pancreatic β-cells is protected by the natural COA water. These findings demonstrate that the natural water COA has a beneficial role in maintaining β cell function through the inhibition of mitochondrial ROS-mediated cell death, and it might be introduced as a potential insulin stabilizer.",
keywords = "3D organoid, Apoptosis, Diabetes, Natural COA water, Pancreatic β-cells, Plk3, Reactive oxygen species (ROS), ex vivo",
author = "Jeyeon Lee and Chung, {Jin Ook} and Park, {Seon Young} and Naveen Rajamohan and Aparna Singh and Kim, {Jung Jin} and Lowe, {Val J.} and Lee, {Seung Baek}",
note = "Funding Information: J.Y.L., J.O.C. and J.J.K. designed and performed most experiments, analyzed data, and prepared the manuscript as a lead author. S.Y.P, N.R., A.S., and V.L. contributed to editing and commenting on the paper. J.J.K., V.L., and S.B.L. supervised the project. This work was supported by grant number E&P-RES20191001-01 to J.J.K and was also supported by grant number E&P-RES20191001-02 to S.B.L. and by the Dorothea Berggren Charitable Foundation. Funding Information: Dr. Lowe is a consultant for AVID Radiopharmaceuticals, Eisai Co. Inc., Bayer Schering Pharma, GE Healthcare, and Merck Research, and receives research support from GE Healthcare, Siemens Molecular Imaging, AVID Radiopharmaceuticals, and NIH (NIA,NCI). Dr. Lee report grants from E&P Co., Ltd. (South Korea) during the conduct of the study. Funding Information: J.Y.L., J.O.C. and J.J.K. designed and performed most experiments, analyzed data, and prepared the manuscript as a lead author. S.Y.P, N.R., A.S., and V.L. contributed to editing and commenting on the paper. J.J.K., V.L., and S.B.L. supervised the project. This work was supported by grant number E&P-RES20191001-01 to J.J.K and was also supported by grant number E&P-RES20191001-02 to S.B.L. and by the Dorothea Berggren Charitable Foundation.We thank the Department of Radiology (Mayo Clinic, Rochester, MN) and Department of Internal Medicine (Chonnam National University Medical School, Korea) for supporting experimentation and data analysis. We thank Christine Song (Mayo High School, Rochester, MN) for editing this paper. Publisher Copyright: {\textcopyright} 2022 The Authors",
year = "2022",
month = jul,
doi = "10.1016/j.bbrep.2022.101247",
language = "English (US)",
volume = "30",
journal = "Biochemistry and Biophysics Reports",
issn = "2405-5808",
publisher = "Elsevier BV",
}